LEAH BOWERS: Open Payments
NPI 1114983665 · GRETNA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,996 in 164 payments from 24 companies in 2025. Trend: 2023 $1,759 · 2024 $2,645 · 2025 $2,996
Food & beverage: $2,996
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 22 | $473 |
| ABBVIE INC. | 25 | $469 |
| AstraZeneca Pharmaceuticals LP | 23 | $397 |
| PFIZER INC. | 13 | $219 |
| Novo Nordisk Inc | 14 | $176 |
| Kowa Pharmaceuticals America, Inc. | 12 | $143 |
| GlaxoSmithKline, LLC. | 7 | $133 |
| Ardelyx, Inc. | 5 | $121 |
| Dexcom, Inc. | 4 | $113 |
| Sumitomo Pharma America, Inc. | 5 | $92 |
Products named: MOUNJARO, BREZTRI, PREVNAR 20, QULIPTA, JARDIANCE, ZEPBOUND, UBRELVY, ZORYVE.
Industry payments across LA — which companies pay providers there.
